NCT05000294 2026-06-05Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesUniversity of FloridaPhase 1/2 Recruiting29 enrolled
NCT06943521 2025-12-11A Study of MT-4561 in Patients With Various Advanced Solid TumorsTanabe Pharma America, Inc.Phase 1/2 Recruiting27 enrolled